Cargando…

Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19

Detalles Bibliográficos
Autores principales: Demaria, Olivier, Carvelli, Julien, Batista, Luciana, Thibult, Marie-Laure, Morel, Ariane, André, Pascale, Morel, Yannis, Vély, Frederic, Vivier, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327215/
https://www.ncbi.nlm.nih.gov/pubmed/32612152
http://dx.doi.org/10.1038/s41423-020-0493-9
_version_ 1783552497598595072
author Demaria, Olivier
Carvelli, Julien
Batista, Luciana
Thibult, Marie-Laure
Morel, Ariane
André, Pascale
Morel, Yannis
Vély, Frederic
Vivier, Eric
author_facet Demaria, Olivier
Carvelli, Julien
Batista, Luciana
Thibult, Marie-Laure
Morel, Ariane
André, Pascale
Morel, Yannis
Vély, Frederic
Vivier, Eric
author_sort Demaria, Olivier
collection PubMed
description
format Online
Article
Text
id pubmed-7327215
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-73272152020-07-01 Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19 Demaria, Olivier Carvelli, Julien Batista, Luciana Thibult, Marie-Laure Morel, Ariane André, Pascale Morel, Yannis Vély, Frederic Vivier, Eric Cell Mol Immunol Correspondence Nature Publishing Group UK 2020-07-01 2020-09 /pmc/articles/PMC7327215/ /pubmed/32612152 http://dx.doi.org/10.1038/s41423-020-0493-9 Text en © CSI and USTC 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Demaria, Olivier
Carvelli, Julien
Batista, Luciana
Thibult, Marie-Laure
Morel, Ariane
André, Pascale
Morel, Yannis
Vély, Frederic
Vivier, Eric
Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19
title Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19
title_full Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19
title_fullStr Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19
title_full_unstemmed Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19
title_short Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19
title_sort identification of druggable inhibitory immune checkpoints on natural killer cells in covid-19
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327215/
https://www.ncbi.nlm.nih.gov/pubmed/32612152
http://dx.doi.org/10.1038/s41423-020-0493-9
work_keys_str_mv AT demariaolivier identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19
AT carvellijulien identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19
AT batistaluciana identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19
AT thibultmarielaure identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19
AT morelariane identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19
AT andrepascale identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19
AT morelyannis identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19
AT velyfrederic identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19
AT viviereric identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19